SynthesisBMC cancer2010

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis.

Tao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.